President Joe Biden’s Department of Justice is asking the Supreme Court to reverse a lower court decision halting two U.S. Food and Drug Administration (FDA) actions that loosened restrictions around mifepristone, the first pill used in a two-drug chemical abortion regimen.
Solicitor General Elizabeth Prelogar told the high court in a petition for a writ of certiorari filed on Friday that if the lower court decision is allowed to take effect, it would “up-end the regulatory regime for mifepristone with damaging consequences for women seeking lawful abortions and a healthcare system that relies on the availability of the drug under the current conditions of use.”
“And the logic of the Fifth Circuit’s unprecedented decision would threaten to severely disrupt the pharmaceutical industry and prevent FDA from fulfilling its statutory responsibilities according to its scientific judgment,” the petition reads.
Danco Laboratories LLC, which distributes mifepristone…
Connect with us on our socials: